Please wait while the formulary information is being retrieved.
Drug overview for ALOMIDE (lodoxamide tromethamine):
Generic name: lodoxamide tromethamine (low-DOX-uh-mide)
Drug class: Ophthalmic Antiallergic Agents
Therapeutic class: Ophthalmic Agents
Lodoxamide tromethamine has been described as a mast-cell stabilizer.
No enhanced Uses information available for this drug.
Generic name: lodoxamide tromethamine (low-DOX-uh-mide)
Drug class: Ophthalmic Antiallergic Agents
Therapeutic class: Ophthalmic Agents
Lodoxamide tromethamine has been described as a mast-cell stabilizer.
No enhanced Uses information available for this drug.
DRUG IMAGES
No Image Available
The following indications for ALOMIDE (lodoxamide tromethamine) have been approved by the FDA:
Indications:
Vernal conjunctivitis
Vernal keratitis
Vernal keratoconjunctivitis
Professional Synonyms:
None.
Indications:
Vernal conjunctivitis
Vernal keratitis
Vernal keratoconjunctivitis
Professional Synonyms:
None.
The following dosing information is available for ALOMIDE (lodoxamide tromethamine):
Safety and efficacy of lodoxamide tromethamine ophthalmic solution in children younger than 2 years of age have not been established. Dosage of lodoxamide tromethamine is expressed in terms of lodoxamide.
Lodoxamide tromethamine is applied topically to the eye as an ophthalmic solution. The manufacturer warns that commercially available lodoxamide tromethamine ophthalmic solution is not for injection and should not be injected subconjunctivally or directly into the anterior chamber of the eye.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for ALOMIDE (lodoxamide tromethamine):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for ALOMIDE (lodoxamide tromethamine):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 0 contraindications.
There are 0 severe contraindications.
There are 1 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
| Moderate List |
|---|
| No disease contraindications |
The following adverse reaction information is available for ALOMIDE (lodoxamide tromethamine):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 18 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. |
Blurred vision Conjunctival hyperemia Eye tearing Foreign body sensation of eye Headache disorder Ocular discharge Ocular itching |
| Rare/Very Rare |
|---|
|
Blepharitis Chemosis Corneal edema Corneal erosion Corneal ulcer Disorder of cornea Dizziness Eyelid edema Keratitis Ocular pain Skin rash |
There are 11 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Ocular irritation |
None. |
| Rare/Very Rare |
|---|
|
Abdominal pain with cramps Drowsy Dry eye Dry nose Eyelid crusting Flushing Nausea Ocular warming sensation Sneezing Sticky sensation of eye |
The following precautions are available for ALOMIDE (lodoxamide tromethamine):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
No enhanced Pregnancy information available for this drug.
No enhanced Lactation information available for this drug.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for ALOMIDE (lodoxamide tromethamine):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for ALOMIDE (lodoxamide tromethamine)'s list of indications:
| Vernal conjunctivitis | |
| H10.44 | Vernal conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
| Vernal keratitis | |
| H10.44 | Vernal conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
| Vernal keratoconjunctivitis | |
| H10.44 | Vernal conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
Formulary Reference Tool